Current Cancer Treatment News and Events | Page 25

Current Cancer Treatment News and Events, Cancer Treatment News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
Study identifies mutations linked to familial pancreatic cancer
Study finds genetic mutations associated with hereditary forms of pancreatic cancer and mechanism by which these mutations may contribute to the development of tumors. (2019-08-15)

More cancer cases among women with sleep apnea
Women with severe sleep apnea appear to be at an elevated risk of getting cancer, a study shows. No causal relationship is demonstrated, but the link between nocturnal hypoxia in women and higher cancer risk is still clear. (2019-08-15)

Chemical screening suggests a two-pronged treatment for pediatric Ewing sarcoma
For children with Ewing sarcoma, an aggressive bone cancer, a combination of two different classes of drugs may work synergistically to turn off the drivers fueling this disease, finds a new study. The combination appears to be more powerful than relying on either treatment alone. (2019-08-14)

Nanocapsule reaches cancer that has spread to central nervous system in mice
Researchers developed a drug delivery system that can break through the blood-brain barrier in mice. (2019-08-14)

Two-pronged gene therapy for glioblastoma proves safe in phase 1 trial
A phase 1 clinical trial has demonstrated that a two-step gene therapy treatment was safe and effective in 31 patients with recurrent glioblastoma -- a stubborn form of brain cancer -- potentially overcoming a major hurdle that has hindered the use of systemically administered interleukin 12 (IL-12)-based regimens. (2019-08-14)

New drug shows encouraging survival in pancreatic cancer
A phase 1 clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. The trial looked at AZD1775, an inhibitor designed to block an enzyme called Wee1, which plays a role in DNA damage repair. (2019-08-14)

Exercise associated with benefit to patients with advanced colorectal cancer
Patients with metastatic colorectal cancer who engaged in moderate exercise while undergoing chemotherapy tended to have delayed progression of their disease and fewer severe side effects from treatment, according to the results of a new study. (2019-08-14)

Inherited pancreatic cancer risk mutation identified
The discovery of the previously unknown mutation, reported in Nature Genetics by investigators from Dana-Farber/Brigham and Women's Cancer Center, could lead to routine testing of individuals with a strong family history of pancreatic cancer to determine if they carry the mutation, occurring in the gene known as RABL3. (2019-08-12)

Key to targeting the spread of pancreatic cancer
Targeting the tissue around pancreatic cancer cells may be the key to stopping their spread and improving chemotherapy outcomes. (2019-08-12)

Manipulating dose, timing of two therapies reduces relapse in mouse models of breast cancer
Changing the standard dose and timing of two therapies greatly cut tumor relapse and reduced side effects in mouse models of kinase mutated breast cancer and lung cancer, UT Southwestern Simmons Cancer Center researchers have found. (2019-08-09)

Nanoparticles' movements reveal whether they can successfully target cancer
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets -- by simply analyzing each nanoparticle's distinct movements in real time. (2019-08-09)

Artificial intelligence could yield more accurate breast cancer diagnoses
UCLA researchers have developed an artificial intelligence system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer. (2019-08-09)

Personalized assay surpasses limits for detecting tumor DNA in breast cancer patients
Scientists have developed a personalized platform tailored to patients' specific cancer mutations named TARDIS, which was able to accurately detect circulating tumor DNA (ctDNA) and signs of residual disease in 33 women with breast cancer. (2019-08-07)

Cancer in the oldest old: The fastest growing age group in the US
A new report looks at cancer in adults 85 and older and finds incidence and mortality trends are generally similar to those in people 65 to 84, but screening is unexpectedly high and survival is poorer. (2019-08-07)

Chemotherapy drugs react differently to radiation while in water
In a new study in EPJ D, researchers at the Leopold-Franzens-University Innsbruck, in Innsbruck, Austria studied the way various molecules, found in chemotherapy drugs, react to ionization by radiation similar to that used in cancer treatment. (2019-08-07)

Substituting poultry for red meat may reduce breast cancer risk
Results from a new study suggest that red meat consumption may increase the risk of breast cancer, whereas poultry consumption may be protective against breast cancer risk. The findings are published in the International Journal of Cancer. (2019-08-07)

Researchers take key step toward cancer treatments that leave healthy cells unharmed
Researchers have opened up a possible avenue for new cancer therapies that don't have the side effects that oftentimes accompany many current cancer treatments by identifying a protein modification that specifically supports survival of tumor cells. (2019-08-05)

Shrinking brain tumours and opening the door for targeted cancer therapies
A new drug, known as IP1867B, could be used for future treatments of brain tumours. The research team showed that IP1867B worked with existing cancer treatments boosting their effectiveness and, in some cases, restored sensitivity to some treatments. (2019-08-05)

AI reveals new breast cancer types that respond differently to treatment
Scientists have used artificial intelligence to recognize patterns in breast cancer -- and uncovered five new types of the disease each matched to different personalized treatments. (2019-08-02)

Despite treatment, elderly cancer patients have worse outcomes if HIV-positive
Elderly cancer patients who are HIV-positive have worse outcomes compared to cancer patients in the same age range who do not have HIV. A new study in JAMA Oncology takes a closer look at the disparity, factoring in whether or not cancer treatment had an impact on outcomes among this patient population. (2019-08-01)

Discovery of distinct lung cancer pathways may lead to more targeted treatments
Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute. Researchers on Mayo Clinic's Florida campus can now distinguish between two pathways where this deadly cancer can develop. They say their discovery could help future patients. The findings appear in Cancer Cell. (2019-08-01)

Study compares HIV, cancer treatments, outcomes in older patients
This study compared outcomes after a cancer diagnosis in patients with and without HIV who were 65 or older, had similar stages of cancer, and had received stage-appropriate cancer treatment in the year following diagnosis. (2019-08-01)

Endometrial diseases can be imitated in a lab dish, new study shows
Biomedical researchers at KU Leuven have found a new way to study endometrial diseases such as endometriosis and cancer. They were able to grow three-dimensional cell structures from diseased tissue of patients. The biobank can be used to unravel the disorders and test drugs. (2019-08-01)

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer. (2019-08-01)

From urine samples to precision medicine in bladder cancer through 3D cell culture
A research collaboration led by scientists from institutions in Japan including Tokyo University of Agriculture and Technology (TUAT) has developed a new experimental cancer model for dog bladder cancer. Urine samples were used for a 3D cell culture method called organoid culture. This method will allow us to quickly determine the proper chemotherapy and to identify new biomarkers of both dog and human bladder cancer in the near future. (2019-07-30)

Stem cell research sheds new light on the skin
For the first time, researchers from the University of Copenhagen have studied and outlined the development of sebaceous glands in the skin. The study provides greater insight into the development and maintenance of the skin and how cancer mutations affect the behavior of stem cells. (2019-07-30)

Adjuvant radiotherapy may be beneficial in treating locally advanced prostate cancer
Adjuvant radiotherapy administered after surgical removal of the prostate prolongs disease-free time as measured by PSA, a Finnish study shows. (2019-07-30)

Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia
Researchers from Case Western Reserve University School of Medicine have developed a new combination treatment regimen that enhances the immune system's ability to kill leukemias that do not respond to standard treatments. The regimen includes a therapeutic antibody designed to draw natural killer immune cells to cancer cells. (2019-07-29)

UVA discovers incredible HULLK that controls prostate cancer progression
Researchers believe the discovery could be used to target and stop the progression of a cancer that kills more than 30,000 American men every year. (2019-07-29)

Lymph nodes can predict survival in patients with esophageal cancer
It is difficult for physicians to estimate recurrence and survival in patients with esophageal cancer. Researchers from Osaka University have found that the response of lymph nodes, as opposed to that of primary tumors, to neoadjuvant chemotherapy is more effective in predicting disease recurrence and patient survival in individuals with metastatic esophageal cancer. This finding is likely to enhance the accuracy of predictions regarding treatment outcome, and may lead to improved treatment approaches. (2019-07-29)

New drug providing hope for babies with aggressive Acute Lymphoblastic Leukaemia
A breakthrough new drug is providing hope to tiny babies at risk of dying from an aggressive form of Acute Lymphoblastic Leukaemia and could help all cancer patients. (2019-07-27)

New gene found for a deadly childhood cancer offers possibility of targeted drug therapy
Neuroblastoma accounts for 15% of total childhood cancer deaths and survival rates of high-risk neuroblastoma patients is 50%. For the first time, Australian researchers from Children's Cancer Institute have discovered that a gene called JMJD6 plays an important role in the most aggressive form of the disease. The discovery opens up a new way to treat neuroblastoma, using drugs that target this gene. (2019-07-26)

Antibiotics can inhibit skin lymphoma
New research from the LEO Foundation Skin Immunology Research Center at the University of Copenhagen shows, surprisingly, that antibiotics inhibit cancer in the skin in patients with rare type of lymphoma. (2019-07-25)

New AI tool developed by Dana-Farber identifies cancer outcomes using radiology reports
Scientists at Dana-Farber Cancer Institute have demonstrated that an artificial intelligence tool can perform as well as human reviewers -- and much more rapidly -- in extracting clinical information regarding changes in tumors from unstructured radiology reports for patients with lung cancer. (2019-07-25)

One dose of HPV vaccine may be enough, Australian research finds
One dose of human papillomavirus (HPV) vaccine has comparable effectiveness to 2 or 3 doses for preventing cervical pre-cancer, according to a new study. (2019-07-24)

Cellular soldiers designed to kill cancer cells that get loose during surgery
Biomedical engineers at Vanderbilt University have discovered a method to track down and kill escaping cancer cells during tumor removal surgeries. The method, which uses the body's own defenses in the form of modified lipid nanoparticles adhered to white blood cells, could preventing metastasis and save lives. (2019-07-24)

Targeted therapy erdafitinib effective for patients with advanced bladder cancer and specific gene mutations
A Phase II clinical trial led by MD Anderson found that treatment with the FGFR inhibitor erdafitinib was effective in 40% of patients with metastatic bladder cancers marked by FGFR3 mutations. The trial results led to FDA approval of the drug. (2019-07-24)

Zhang group identifies gene that may make TNBC cells vulnerable to existing
A new study by University of Notre Dame researcher Siyuan Zhang and collaborators, published in Nature Communications, shows that an existing, FDA-approved drug that treats other types of breast cancer may work for TNBC. (2019-07-23)

Gene test picks out prostate cancers that could respond to 'search-and-destroy' medicine
Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports. An emerging class of drugs are made up of a radioactive particle that kills cells attached to a 'homing device' to seek out cancers by detecting the presence of a target molecule on their surface. These new 'search-and-destroy' treatments are starting to show promise -- but not all patients respond. (2019-07-22)

Biomaterial-delivered chemotherapy leads to long-term survival in brain cancer
A combination of chemotherapy drugs during brain cancer surgery using a biodegradable paste, leads to long-term survival, researchers at the University of Nottingham have discovered. (2019-07-18)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.